Sulindac-derived RXRα modulators inhibit cancer cell growth by binding to a novel site of RXRα

Retinoid X receptor-alpha (RXRα), an intriguing and unique drug target, can serve as an intracellular target mediating the anti-cancer effects of certain non-steroidal anti-inflammatory drugs (NSAIDs), including Sulindac. We report the synthesis and characterization of two new Sulindac analogs, K-80...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Chen, Liqun, Wang, Zhi-Gang, Aleshin, Alexander, Chen, Fan, Chen, Jiebo, Jiang, Fuquan, Alitongbieke, Gulimiran, Zeng, Zhiping, Ma, Yue, Huang, Mingfeng, Zhou, Hu, Cadwell, Gregory, Zheng, Jian-Feng, Huang, Pei-Qiang, Liddington, Robert, Zhang, Xiao-kun, Su, Ying
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4035439/
https://ncbi.nlm.nih.gov/pubmed/24704507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chembiol.2014.02.017
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars